Antifungal agents: Their diversity and increasing sophistication

Mycologist

Volumn 17, Issue 2, 2003, Pages 51-55

  Odds, Frank C ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Antifungal agents; Azoles; Drug discovery; Echinocandins; Mycosis; Polyenes

Indexed keywords

EID: 0142134314     PISSN: 0269915X     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0269915X03002064     Document Type: Review

References (8)

1. Dupont B. (2002). Overview of the lipid formulations of amphotericin B. Journal of Antimicrobial Chemotherapy 49, suppl. 1: 31-36.
2. Hoffman H. L., Ernst E. J. & Klepser M. E. (2000). Novel triazole antifungal agents. Expert Opinion on Investigational Drugs 9: 593-605.
3. McClellan K. J., Wiseman L. R. & Markham A. (1999). Terbinafine. An update of its use in superficial mycoses. Drugs 58: 179-202.
4. Odds, F. C. (2001). Sordarin antifungal agents. Expert Opinion on Therapeutic Patents 11: 283-294.
5. Sheehan D. J., Hitchcock C. A. & Sibley C. M. (1999). Current and emerging azole antifungal agents. Clinical Microbiology Reviews 12: 40-79.
6. Vanden Bossche, H. (2002). Echinocandins - an update. Expert Opinion on Therapeutic Patents 12: 151-157.
7. Vermes A. Guchelaar H. J. & Dankert, J. (2000). Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions. Journal of Antimicrobial Chemotherapy 46: 171-179.
8. Willins D. A., Kessler M., Walker S. S., Reyes G. R. & Cottarel G. (2002). Genomics strategies for antifungal drug discovery - from gene discovery to compound screening. Current Pharmaceutical Design 8: 1137-1154.